XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Total Crown Equity
Common Stock
Paid-in Capital
Accumulated Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2020 $ 2,604 $ 2,198 $ 929 $ 179 $ 4,538 $ (3,193) $ (255) $ 406
Net income 245 211     211     34
Other comprehensive income (5) (5)       (5)   0
Dividends paid to shareholders (27) (27)     (27)      
Dividends paid to noncontrolling interests (9)             (9)
Restricted stock awarded 0     (1)     1  
Stock-based compensation 11 11   11        
Common stock issued 1 1   1        
Common stock repurchased (12) (12)   (11)     (1)  
Balance at end of period at Mar. 31, 2021 2,808 2,377 929 179 4,722 (3,198) (255) 431
Balance at beginning of period at Dec. 31, 2020 2,604 2,198 929 179 4,538 (3,193) (255) 406
Net income 418              
Other comprehensive income 71              
Balance at end of period at Jun. 30, 2021 2,724 2,262 929 0 4,724 (3,123) (268) 462
Balance at beginning of period at Dec. 31, 2020 2,604 2,198 929 179 4,538 (3,193) (255) 406
Common stock repurchased (950)              
Balance at end of period at Dec. 31, 2021 2,330 1,912 929 0 3,180 (1,898) (299) 418
Balance at beginning of period at Mar. 31, 2021 2,808 2,377 929 179 4,722 (3,198) (255) 431
Net income 173 128     128     45
Other comprehensive income 76 75       75   1
Dividends paid to shareholders (26) (26)     (26)      
Dividends paid to noncontrolling interests (15)             (15)
Restricted stock awarded 0     (1)     1  
Stock-based compensation 6 6   6        
Common stock repurchased (298) (298)   (184) (100)   (14)  
Balance at end of period at Jun. 30, 2021 2,724 2,262 929 0 4,724 (3,123) (268) 462
Balance at beginning of period at Dec. 31, 2021 2,330 1,912 929 0 3,180 (1,898) (299) 418
Net income 246 216     216     30
Other comprehensive income 62 59       59   3
Dividends paid to shareholders (27) (27)     (27)      
Dividends paid to noncontrolling interests (11)             (11)
Restricted stock awarded 0       (1)   1  
Stock-based compensation 10 10     10      
Common stock repurchased (350) (350)     (335)   (15)  
Balance at end of period at Mar. 31, 2022 2,260 1,820 929 0 3,043 (1,839) (313) 440
Balance at beginning of period at Dec. 31, 2021 2,330 1,912 929 0 3,180 (1,898) (299) 418
Net income 575              
Other comprehensive income (55)              
Common stock repurchased (600)              
Balance at end of period at Jun. 30, 2022 2,190 1,739 929 0 3,079 (1,946) (323) 451
Balance at beginning of period at Mar. 31, 2022 2,260 1,820 929 0 3,043 (1,839) (313) 440
Net income 329 295     295     34
Other comprehensive income (117) (107)       (107)   (10)
Dividends paid to shareholders (26) (26)     (26)      
Dividends paid to noncontrolling interests (13)             (13)
Restricted stock awarded 0       (1)   1  
Stock-based compensation 6 6     6      
Common stock issued 1 1     1      
Common stock repurchased (250) (250)     (239)   (11)  
Balance at end of period at Jun. 30, 2022 $ 2,190 $ 1,739 $ 929 $ 0 $ 3,079 $ (1,946) $ (323) $ 451